Market Cap
₹1,205 Cr.
P/E
65.25
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Forensics
Other Income
Other Income is not affecting ratios of the company
Capex vs ROCE
ROCE of the company has decreased even without significant capex
Pledge
Promoters have not pledged a significant portion of their holding
Revenue Recognition
Company is converting accounting profit to cash
Depreciation Effect
Depreciation accounting is not leading to increase in profits
Contingent Liabilities
Company does not have significant contingent liabilities
Retail Holding
Retail has been selling the stock which is usually a good time to buy
Share price
Share price has increased over last 10 years but more due to rerating
ROE
Asset Turnover is responsible for ROE increase over last 10 years
Working Capital
Company has significant working capital which is dragging its ROCE and ROE
Debt
Company should not have issues servicing its debt
Promoter Holding
Promoter has not sold any shares in the last 90 days
Current vs Historic Valuation
Company is trading at a discount to 3 year historic valuations
ROE
Latest
9.52%
3yr Average
13.24%
5yr Average
15.53%
Net Profit Margin
Latest
10.01%
3yr Average
14.27%
5yr Average
16.41%
ROCE
Latest
8.65%
3yr Average
12.7%
5yr Average
15.89%
Debt to Equity
Latest
0.96
3yr Average
0.76
5yr Average
0.68
Market Share
35% (as of Dec 23)
Poultry Vaccines - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Distribution Channel

locked
Source
|
Latest
|
locked
Historic

Operating Profit Break-Up

locked
Source
|
Latest
|
locked
Historic

Capex

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up -Segment

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    Select a Metric
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Company Filing
    Show Previous Years
    Discussions & Analysis